However, looking at the changes in EORTC-QLQ-C30 and QLQ-LC13 scores, the addition of chemotherapy showed a trend toward deterioration in fatigue and appetite loss.
← all excerpts
Survival, toxicity, and sequencing: navigating the new first-line standard established by FLAURA2.
1
—
—